Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
285.40
-3.60 (-1.25%)
At close: Apr 17, 2025, 4:00 PM HKT

HKG:6990 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-266.77-574.13-616.1-889.8
Depreciation & Amortization
91.3975.0867.3622.91
Loss (Gain) From Sale of Assets
0.151.49-5.420.01
Loss (Gain) From Sale of Investments
-21.55-10.53-0.51-0.36
Stock-Based Compensation
148.29123.3519.816.5
Other Operating Activities
99.97168.8229.4995.71
Change in Accounts Receivable
-88.97-124.37-20.130.24
Change in Inventory
-47.47-10.426.07-37.28
Change in Accounts Payable
-50.52252.6250.5790.67
Change in Unearned Revenue
-322.68294.346.2109.04
Change in Other Net Operating Assets
28.4-136.67-28.2116.42
Operating Cash Flow
-429.7759.56-270.85-485.94
Capital Expenditures
-77.46-80.98-33.66-94.08
Sale of Property, Plant & Equipment
0.030.016.33-
Sale (Purchase) of Intangibles
-3.66-1.27-5.33-0.66
Investment in Securities
-740.92-943.170.510.36
Investing Cash Flow
-822.01-1,025-32.15-94.38
Short-Term Debt Issued
--363225.48
Total Debt Issued
--363225.48
Short-Term Debt Repaid
--394.04-45-70
Long-Term Debt Repaid
-54.6-66.76-1.62-1.99
Total Debt Repaid
-54.6-460.8-46.62-71.99
Net Debt Issued (Repaid)
-54.6-460.8316.38153.49
Issuance of Common Stock
1,0942,853-533.81
Other Financing Activities
-2.29-10.01-2.93-39.99
Financing Cash Flow
1,0372,382313.45647.32
Foreign Exchange Rate Adjustments
22.2919.390.71-1.39
Net Cash Flow
-192.271,43611.1765.6
Free Cash Flow
-507.23-21.42-304.51-580.03
Free Cash Flow Margin
-26.24%-1.39%-37.88%-1794.52%
Free Cash Flow Per Share
-2.29-0.12-3.19-6.27
Cash Interest Paid
2.2910.012.9339.99
Levered Free Cash Flow
-368.86-438.58-174.83-
Unlevered Free Cash Flow
-366.49-385.88-81.82-
Change in Net Working Capital
392.47218.49-116.22-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.